|1.||Pyne, Susan: 22 articles (09/2014 - 05/2006)|
|2.||Pyne, Nigel J: 22 articles (09/2014 - 05/2006)|
|3.||Spiegel, Sarah: 21 articles (12/2015 - 04/2002)|
|4.||Obeid, Lina M: 19 articles (11/2015 - 09/2005)|
|5.||Milstien, Sheldon: 17 articles (12/2015 - 04/2002)|
|6.||Pitson, Stuart M: 17 articles (08/2015 - 10/2003)|
|7.||Cuvillier, Olivier: 16 articles (05/2015 - 12/2005)|
|8.||Smith, Charles D: 13 articles (12/2015 - 09/2003)|
|9.||Bittman, Robert: 12 articles (09/2014 - 10/2010)|
|10.||Huwiler, Andrea: 11 articles (01/2014 - 12/2005)|
10/01/2013 - "Sphingosine kinase 2's (SphK2) impact on inflammation is less well known, as variable results were reported depending on the disease model. "
04/01/2011 - "The importance of SphK (sphingosine kinase) and S1P in inflammation has been demonstrated extensively. "
06/01/2010 - "Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation."
05/21/2010 - "A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury."
01/01/2010 - "These findings suggest that sphingosine kinase inhibitors such as SKI-II have an ability to prevent the development of BSM hyperresponsiveness, but not of allergic airway inflammation. "
12/01/2012 - "Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice."
07/01/2015 - "Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice."
04/01/2014 - "Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance."
12/01/2012 - "Intracellular ceramide accumulation causes insulin resistance, but sphingosine kinase 1 (SphK1) prevents ceramide accumulation, in part, by promoting its metabolism into S1P. "
01/01/2013 - "The objective of this study was to examine the effects of short (2 h) and prolonged (18 h) inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate (PA) induced insulin resistance in L6 myotubes. "
|3.||Breast Neoplasms (Breast Cancer)
11/01/2014 - "Sphingosine kinase 1 isoform-specific interactions in breast cancer."
08/15/2014 - "Among the various molecular subtypes of breast cancer, it was observed that TNBCs express elevated levels of sphingosine kinase 1 (SPHK1) compared to other breast tumor subtypes. "
10/01/2013 - "Sphingosine kinase 1 (SphK1) expression has a prognostic impact in primary breast cancer, but its predictive value is currently unknown. "
10/01/2011 - "The roles of antiapoptotic sphingosine kinase-1 and glucosylceramide genes in drug induced cell death of MCF-7 breast cancer cells."
04/01/2011 - "Sphingosine kinase-1 (Sphk1) is a proposed key regulator of breast cancer tumorigenesis, proliferation and resistance. "
12/01/2013 - "This study investigated whether isoflurane ameliorates neurological sequelae after germinal matrix hemorrhage (GMH) through activation of the cytoprotective sphingosine kinase/sphingosine-1-phosphate receptor/Akt pathway. "
06/01/2012 - "Effects of a sphingosine kinase inhibitor N, N-dimethylsphingosine or a sphingosine 1 phosphate receptor inhibitor VPC23019 on isoflurane's protective action against postsubarachnoid hemorrhage early brain injury were also examined. "
|5.||Crohn Disease (Crohn's Disease)
04/01/2010 - "Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease."
04/01/2010 - "Sphingosine kinase may be a critical mediator of colonic damage during intestinal inflammation, and pharmacologic inhibitors of this enzyme may prove useful in the treatment of Crohn's disease."
07/01/2010 - "This conference report highlights selected presentations on the apolipoprotein E-mimetic peptide COG-112 (Cognosci Inc) for the potential treatment of Citrobacter rodentium-induced colitis; the inhibition of sphingosine kinase with ABC-294640 (Apogee Biotechnology Corp) to alleviate stress after hepatic ischemia-reperfusion injury; TLR4 targeting with NI-0101 (NovImmune SA) to prevent colitis-associated cancer; immunization against TNF with TNFalpha kinoid (Neovacs SA) for the treatment of patients with Crohn's disease; and preclinical studies with the anti-inflammatory agent minnelide (University of Minnesota) for the treatment of pancreatic cancer."
|5.||Proteins (Proteins, Gene)
|7.||Calcium Channels (Calcium Channel)
|1.||Drug Therapy (Chemotherapy)
|3.||Homologous Transplantation (Allograft)